home
portfolio
team
careers
contact
investor portal
home
portfolio
team
careers
contact
investor portal
Nextech Invest
Cancer biotech TRACON Pharmaceuticals files for a $58 million IPO
Cancer biotech TRACON Pharmaceuticals files for a $58 million IPO
Post navigation
Previous Post
Previous
TRACON Pharmaceuticals Announces Pricing of Initial Public Offering
Next Post
Next
MacroGenics Enters Collaboration and License Agreement with Janssen to Develop MGD011 for Multiple B-Cell Malignancies